Navigation Links
Reportlinker Adds TOP 10 DRUG DISCOVERY TECHNOLOGIES - STRATEGIC ANALYSIS AND GLOBAL FORECASTS
Date:11/18/2010

NEW YORK, Nov. 18, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

TOP 10 DRUG DISCOVERY TECHNOLOGIES – STRATEGIC ANALYSIS AND GLOBAL FORECASTS

http://www.reportlinker.com/p0330501/TOP-10-DRUG-DISCOVERY-TECHNOLOGIES-–-STRATEGIC-ANALYSIS-AND-GLOBAL-FORECASTS.html

Top 10 drug discovery technologies – strategic analysis and global forecasts (2010 to 2015)

The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies. The applications of these technologies in the introduction of drugs for diverse diseases such as cancer, CVD, CNS disorders such as Parkinson's and Alzheimer's and other serious chronic diseases have created significant opportunities for the market growth in the future. The slow growth of the introduction of new blockbuster drugs is a major concern which the drug development companies are catering to by using these top technologies.

The global top 10 drug discovery technologies market is expected to be around $ 30.8 billion in 2010 and estimated to reach $ 54 billion mark in 2015, growing at a CAGR of 11.9 % from 2010-2015. The market for high throughput screening accounts for the largest share with approximately 33% of the entire market for top 10 drug discovery technologies. This huge market share is mainly due to the increasing applications of cell based assays and robotics in the parallel screening of compounds.

Scope of the reportThis research report includes following drug discovery technologies:

• High throughput screening (robotics and automation, cell based assays, miniaturization, high content screening and ultra high throughput screening)

• Bioanalytical instruments (mass spectrometry, NMR, micro plate readers and chemotherapy instruments)

• Pharmacogenomics

• Combinatorial chemistry

• Genomics (functional and structural genomics)

• Biochips (DNA microarrays, lab on a chip, proteomics microarrays)

• Bioinformatics

• Proteomics (2DGE, two hybrid systems, isotope encoding and activity based assays)

• RNAi (siRNA, miRNA, ddRNAi, short hairpin RNAs)

• Nanotechnology (Atomic force microscopy, nano mass spectroscopy, dip pen nanolithography and other nanotechnologies)

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report also provides more than 20 company profiles covering all the sub-segments.

What makes our reports unique?- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

- Comprehensive market analysis for the following sectors:

Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials?

- What are market estimates and forecasts; which markets are doing well and which are not?

- Where are the gaps and opportunities; what is driving the market?

- Which are the key playing fields? Which are the winning edge imperatives?

- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysisThe analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

TABLE OF CONTENTSEXECUTIVE SUMMARY• Objective

• Market scenario

1 INTRODUCTION 1.1 Key take-aways

1.2 Report description

1.3 Markets covered

1.4 Research methodology

1.5 Stakeholders

2 SUMMARY 3 MARKET OVERVIEW 3.1 Market segmentation

3.2 High throughput screening & bioanalytical instruments leading the market

3.3 Patent analysis

4 DRIVING FACTOR ANALYSIS

4.1 Drivers

4.1.1 Contract research boosting technology adoption

4.1.2 Collaborations between academia & pharmaceutical industry

4.1.3 Increased necessity for ADME/toxicity technologies

4.2 Opportunities

4.2.1 Offshoring scenario for drug discovery

5 HIGH THROUGHPUT SCREENING

5.1 Introduction

5.2 Market overview

5.3 Burning issues & winning imperatives

5.3.1 Increasing participation from academic research

5.3.2 High throughput screening set up: pharmaceutical vs academic

5.4 Ultra high throughput screening

5.5 Robotics & automation

5.6 Miniaturization

5.7 High content screening

5.7.1 Opportunities

5.7.1.1 GPCR drug discovery

5.8 Cell based assays

6 BIOANALYTICAL INSTRUMENTS

6.1 Introduction

6.2 Burning issues & trends

6.2.1 Pharmaceutical industry a major end client

6.2.2 Agilent penetration in bioanalytical instruments market

6.2.3 Outsourcing scenario

6.3 Mass spectrometry

6.3.1 Upcoming technology - Maldi-QMS

6.4 Microplate readers

6.5 Nuclear magnetic resonance

6.6 Chemotherapy instruments

7 Pharmacogenomics

7.1 Introduction

7.2 Pharmacogenomics applications in drug development

7.3 Burning issues

7.3.1 Commercial hurdles in drug development

7.3.1.1 Cost issues in clinical development

7.3.1.2 FDA approval

7.3.1.3 Ethical issues

7.3.2 Pharmacogenomics for drug reintroduction

7.3.3 Pharmacogenomics applications in existing drugs

7.4 Key trends in the pharmacogenomics technology market

7.4.1 Regulatory initiatives boosting adoption for pharmacogenomics technology

7.4.2 Rise in pharmacogenomics consortia boost technology based research

7.4.3 Increasing importance of databases

7.5 Future prospects for pharmacogenomics technology research

7.6 Pharmacogenomics products: pricing effects

7.6.1 Case study: high priced herceptin

7.6.2 Pharmacogenomics cost effectiveness

7.7 Pharmacogenomics technology: short & long term benefits

7.7.1 Improvement in patient safety

7.7.2 Increase in drug effectiveness

7.7.3 Selection of medication for chronic diseases

7.7.4 Better economic efficiency for the healthcare system

7.7.5 Improved patient access to drugs

8 COMBINATORIAL CHEMISTRY

8.1 Introduction

8.2 Market drivers

8.2.1 Technological advances boost adoption of combinatorial chemistry

8.2.2 Process enhancement results in better compounds

8.2.3 Collaborative approach

8.2.4 Need for novel compounds acts as market opportunity

8.3 Stakeholders characteristics

8.4 Burning issues

8.5 Key trends and market boosters

8.5.1 Increased recognition of combinatorial chemistry technology

8.5.2 Faster drug discovery

9 GENOMICS

9.1 Introduction

9.2 Winning imperatives

9.2.1 Reducing cost for whole genome sequencing

9.3 Functional genomics

9.4 Structural genomics

10 BIOCHIPS 10.1 Introduction

10.2 Burning issues

10.2.1 Business trends

10.2.2 Patent disputes

10.2.3 Competition

10.3 Industry trends

10.3.1 Next generation technology: microfluidics with CD-ROM

10.3.2 Biochips in biomarker development

10.3.3 Outsourcing the biochip technology

10.4 DNA microarrays

10.4.1 Market drivers

10.4.1.1 Increased utilization in complex diseases

10.4.1.2 Sequence data proliferation

10.4.1.3 Easy-access programs

10.5 Lab on a chip

10.5.1. New technology & cost saving by lab on a chip boost the market

10.6 Proteomics microarrays

10.6.1 Burning issues and trends

10.6.1.1 Technical lags

10.6.1.2 Human protein microarray for multiple protein analysis

11 BIOINFORMATICS

11.1 Introduction

11.2 Burning issues and trends

11.2.1 Outsourcing

11.2.2 Allocation of grants

12 PROTEOMICS

12.1 Introduction

12.2 Industry trends

12.2.1 Funding for proteomics research

12.2.2 Proteomics in anti cancer drug discovery

12.3 Two dimensional gel electrphoresis- 2DGE

12.4 Two-hybrid systems

13 RNAI

13.1 Technology overview

13.2 Winning imperatives

13.2.1 Core competency acquisition

13.3 Opportunity in RNAi drug discovery

13.3.1 RNAi based cholesterol drugs

13.3.2 Cancer drugs

13.4 SiRNA

13.5 MiRNAS

13.6 Other RNAi technologies

14 NANOTECHNOLOGY 14.1 Introduction

14.2 Healthcare application areas for nanotechnology

14.2.1 Biomedical research

14.2.2 Therapeutics

14.2.3 Diagnostics

14.3 Burning issues and trends

14.3.1 Regulatory & health issues

14.3.2 Increase in funding

14.4 Atomic force microscopy (AFM)

14.5 Nano-mass spectroscopy

14.6 Dip-pen Nanolithography

15 GEOGRAPHICAL ANALYSIS

15.1 Introduction

15.2 North America

15.3 Europe

15.4 Asia

15.5 ROW

16 COMPETITIVE LANDSCAPE

16.1 Market share for drug discovery technologies

16.2 Agreements & collaborations

16.3 New product launch

16.4 End clients for top 10 drug discovery technologies

17 COMPANY PROFILES

17.1 ABBOTT LABORATORIES INC.

17.1.1 Overview

17.1.2 Primary business

17.1.3 Strategy

17.1.4 Developments

17.2 AFFYMETRIX INC.

17.2.1 Overview

17.2.2 Primary business

17.2.3 Strategy

17.2.4 Developments

17.3 AGILENT TECHNOLOGIES INC.

17.3.1 Overview

17.3.2 Primary business

17.3.3 Strategy

17.3.4 Developments

17.4 ALBANY MOLECULAR RESEARCH INC.

17.4.1 Overview

17.4.2 Primary business

17.4.3 Strategy

17.4.4 Developments

17.5 ARQULE INC.

17.5.1 Overview

17.5.2 Primary business

17.5.3 Strategy

17.5.4 Developments

17.6 ASTRAZENECA PLC.

17.6.1 Overview

17.6.2 Primary business

17.6.3 Strategy

17.6.4 Developments

17.7 BIO-RAD LABORATORIES INC.

17.7.1 Overview

17.7.2 Primary business

17.7.3 Strategy

17.7.4 Developments

17.8 CALIPER LIFE SCIENCES INC.

17.8.1 Overview

17.8.2 Primary business

17.8.3 Strategy

17.8.4 Developments

17.9 CELERA CORP

17.9.1 Overview

17.9.2 Primary business

17.9.3 Strategy

17.9.4 Developments

17.10 CHARLES RIVER LABORATORIES INTERNATIONAL INC.

17.10.1 Overview

17.10.2 Primary business

17.10.3 Strategy

17.10.4 Developments

17.11 CHEMBRIDGE CORP

17.11.1 Overview

17.11.2 Primary business

17.11.3 Strategy

17.11.4 Developments

17.12 EVOTEC AG

17.12.1 Overview

17.12.2 Primary business

17.12.3 Strategy

17.12.4 Developments

17.13 F. HOFFMANN-LA ROCHE LTD.

17.13.1 Overview

17.13.2 Primary business

17.13.3 Strategy

17.13.4 Developments

17.14 GYROS AB

17.14.1 Overview

17.14.2 Primary business

17.14.3 Strategy

17.14.4 Developments

17.15 INCYTE CORP

17.15.1 Overview

17.15.2 Primary business

17.15.3 Strategy

17.15.4 Developments

17.16 LIFE TECHNOLOGIES CORP

17.16.1 Overview

17.16.2 Primary business

17.16.3 Strategy

17.16.4 Developments

17.17 SHIMADZU CORP

17.17.1 Overview

17.17.2 Primary business

17.17.3 Strategy

17.17.4 Developments

17.18 PERKINELMER INC.

17.18.1 Overview

17.18.2 Primary business

17.18.3 Strategy

17.18.4 Developments

17.19 SIGMA-ALDRICH CORP

17.19.1 Overview

17.19.2 Primary business

17.19.3 Strategy

17.19.4 Developments

17.20 TECAN GROUP LTD.

17.20.1 Overview

17.20.2 Primary business

17.20.3 Strategy

17.20.4 Developments

17.21 THERMO FISHER SCIENTIFIC INC.

17.21.1 Overview

17.21.2 Primary business

17.21.3 Strategy

17.21.4 Developments

APPENDIX

• U.S. patents

• EUROPE patents

• JAPAN patents

LIST OF TABLES 1 Global top 10 drug discovery technologies market 2008 – 2015 ($Million)

2 Estimated time saving by CRO in clinical trials

3 Global high throughput screening market, by products 2008 – 2015 ($Million)

4 High throughput screening market, by geography 2008 – 2015 ($Million)

5 HTS infrastructural/resource comparison for pharmaceutical and academic centers

6 Ultra high throughput screening market, by geography 2008 – 2015 ($Million)

7 Robotics and automation market, by geography 2008 – 2015 ($Million)

8 Miniaturization market, by geography 2008 – 2015 ($Million)

9 High content screening market, by geography 2008 – 2015 ($Million)

10 Cell based assays market, by geography 2008 – 2015 ($Million)

11 Global bioanalytical instruments market, by products 2008 – 2015 ($Million)

12 Bioanalytical instruments market, by geography 2008 – 2015 ($Million)

13 Global mass spectrometry market, by products 2008 – 2015 ($Million)

14 Mass spectrometry market, by geography 2008 – 2015 ($Million)

15 Microplate Readers Market, By Geography 2008 – 2015 ($Million)

16 NMR market, by geography 2008 – 2015 ($Million)

17 Chemotherapy instruments market, by geography 2008 – 2015 ($Million)

18 Pharmacogenomics market, by geography 2008 – 2015 ($Million)

19 Combinatorial chemistry market, by geography 2008 – 2015 ($Million)

20 Cost comparison between traditional and combinatorial chemistry

21 Global genomics market, by products 2008 – 2015 ($Million)

22 Genomics market, by geography 2008 – 2015 ($Million)

23 Functional genomics market, by geography 2008 – 2015 ($Million)

24 Structural genomics market, by geography 2008 – 2015 ($Million)

25 Global biochips market, by segment 2008 – 2015 ($Million)

26 Biochips market, by geography 2008 – 2015 ($Million)

27 Patent disputes within the biochips market

28 DNA microarrays market, by geography 2008 – 2015 ($Million)

29 Lab on a chip market, by geography 2008 – 2015 ($Million)

30 Proteomics microarrays market, by geography 2008 – 2015 ($Million)

31 Global bioinformatics market, by products 2008 – 2015 ($Million)

32 Bioinformatics market, by geography 2008 – 2015 ($Million)

33 Global proteomics market, by products2008 – 2015 ($Million)

34 Proteomics market, by geography 2008 – 2015 ($Million)

35 2DGE market, by geography 2008 – 2015 ($Million)

36 Two hybrid systems market, by geography 2008 – 2015 ($Million)

37 Global RNAi market, by products 2008 – 2015 ($Million)

38 RNAi market, by geography 2008 – 2015 ($Million)

39 SiRNA market, by geography 2008 – 2015 ($Million)

40 MiRNA market, by geography 2008 – 2015 ($Million)

41 Global other RNAi technologies market, by products 2008 – 2015 ($Million)

42 Other RNAi technologies market, by geography 2008 – 2015 ($Million)

43 Global nanotechnology market, by products 2008 – 2015 ($Million)

44 Nanotechnology market, by geography 2008 – 2015 ($Million)

45 Comparison of AFM technology with other microscopy technology

46 Atomic force microscopy market, by geography 2008 – 2015 ($Million)

47 Nano-mass spectroscopy market, by geography 2008 – 2015 ($Million)

48 Dip-pen Nanolithography market, by geography 2008 – 2015 ($Million)

49 North American top 10 drug discovery technologies market 2008 – 2015 ($Million)

50 European top 10 drug discovery technologies market 2008 – 2015 ($Million)

51 Asian top 10 drug discovery technologies market 2008 – 2015 ($Million)

52 RoW top 10 drug discovery technologies market 2008 – 2015 ($Million)

53 Agreements and collaborations (2009 – 2010)

54 New product development (2009 – 2010)

LIST OF FIGURES

1 Revenue analysis for top 10 drug discovery technologies

2 Top 10 drug discovery technologies market segmentation

3 Relative market scenario (2010)

4 Patent analysis by geography

5 Patent analysis by competitors 2005 – 2010

6 High throughput screening in drug discovery

7 Approximate industrial demand for bioanalytical instruments (2010)

8 Cost saving in comparison with high throughput screening

9 Approximate end client share for microplate readers

10 Drug development process and pharmacogenomics applications

11 Future advancements in the pharmacogenomics research

12 Cost associated with pharmacogenomics based tests

13 Long term goals/benefits for pharmacogenomics

14 Dollar value offered, by technology providers

15 Time and cost saving by implementation of combinatorial chemistry

16 Reducing costs for whole genome sequencing

17 Major end clients for biochip technology market

18 Historical data for DNA microarray based collaborations

19 Applications of lab-on-a-chip technology in drug discovery

20 MiRNA research efforts

21 Applications areas of MiRNA

22 MiRNA in drug discovery

23 Nanotechnology applications

24 Global market for top 10 drug discovery technologies

25 Approximate market share for overall drug discovery technologies

26 Approximate end client share for top 10 drug discovery technologies

To order this report:Biotechnology Industry: TOP 10 DRUG DISCOVERY TECHNOLOGIES – STRATEGIC ANALYSIS AND GLOBAL FORECASTS

Biotechnology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Global HPLC Systems & Accessories Industry
2. Reportlinker Adds Global Blood Pressure Monitoring & Measurement Instruments Industry
3. Reportlinker Adds Global Freeze Drying Equipment Industry
4. Reportlinker Adds Global Surgical Incision Closures Industry
5. Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
6. Reportlinker Adds Global Uro-Gynecological Surgical Devices Industry
7. Reportlinker Adds Global Sterilization Systems & Equipment Industry
8. Reportlinker Adds Global Breast Pumps Industry
9. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
10. Reportlinker Adds Global Nutraceuticals Industry
11. Reportlinker Adds Global Agricultural Biotechnology Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  Venice,s newest ... is the first of its kind in the ... tattoos through advanced laser treatment. The physician-owned and ... Suncoast by storm with its revitalizing ... and advanced multi-wavelength Astanza Trinity technology. ...
(Date:2/5/2016)... 5, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... announced underwritten secondary offering of 11,027,558 shares of its ... affiliates of Blackstone and Goldman Sachs.  The shares are ... of $96.45 per share. The selling stockholders will receive ... Biomet nor any of its directors, officers or other ...
(Date:2/5/2016)... Site Profile: --> Site ... People, announced their latest primary healthcare case study where speech recognition ... and to save the practice money. Site Profile: ... Challenge: --> ,- Wirral CCG ,- VoicePower client since ... Wirral CCG ,- VoicePower client since 2013 Challenge: ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... 2016 , ... The Muscular Dystrophy Association and Sailormen Inc., ... 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise critical ... diseases that severely limit strength and mobility. , Now through March 20, ...
(Date:2/5/2016)... Tennessee (PRWEB) , ... February 05, 2016 , ... ... Community College President George H. Van Allen have signed a joint enrollment and ... provides a seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , ...
(Date:2/5/2016)... ... 2016 , ... US Sports Camps , official operators of Nike Yoga ... kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New England ... Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering ...
(Date:2/5/2016)... New York (PRWEB) , ... February 05, 2016 , ... ... use and find themselves having to wait longer to access the treadmills. It’s a ... New Year’s resolutions to lose weight and get in shape by joining gyms, starting ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
Breaking Medicine News(10 mins):